Uterine fibroids can cause pain and heavy bleeding and are a common indication for hysterectomy, but little evidence exists to guide fibroid management (AHRQ Research Report, March 2011). The ...

The European Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that women stop using 5-mg ulipristal acetate (Esmya, Gedeon Richter, and generics) for ...

(HealthDay News) – For women with symptomatic fibroids, a daily dose of 5mg or 10mg oral ulipristal acetate is efficacious for controlling uterine bleeding before surgery, compared with placebo or ...

SALT LAKE CITY — When uterine fibroids were treated with the selective progesterone-receptor modulator ulipristal acetate, rates of amenorrhea, defined as no menstrual bleeding for 35 consecutive days ...

DUBLIN, Oct. 31, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) presented new analyses of VENUS II, the second of two pivotal Phase 3 clinical trials evaluating the efficacy and safety of ulipristal ...

(RTTNews) - Allergan plc (AGN) said that the U.S. Food and Drug Administration has accepted the New Drug Application or NDA for ulipristal acetate, an investigational drug for the treatment of ...

Allergan Plc and Gedeon Richter Plc. announced positive results from Venus II, the second of two pivotal phase III clinical trials evaluating the efficacy and safety of ulipristal acetate in women ...

A new, effective, non-surgical treatment for uterine fibroids can help women with this condition maintain their fertility. The outcome of two Phase II clinical trials of ulipristal acetate has ...

If uterine fibroids will affect more than 80 percent of women in the United States by the time they are 50 years old, then why has such little research been done about the gynecological disorder? What ...

Irish drugmaker Allergan has posted a full house of met endpoints in a late-stage benign uterine tumors trial using a form of the drugmaker’s contraceptive pill Ella. Allergan and London-based ...

Fibroids are non-cancerous tumors that develop inside a woman’s uterus, and up to 70 percent of all women will have uterine fibroids in their lifetime. Scientists aren’t sure exactly what causes these ...